Navigation Links
Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
Date:5/9/2008

DANBURY, Conn., May 9 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for its second quarter ended March 31, 2008. The net loss for the quarter was $9.6 million or $0.43 per share.

"We remain on track in our development of VIAject(TM)," stated Dr. Solomon Steiner, CEO and Chairman of Biodel. "The last patient visits for both pivotal Phase III clinical trials are scheduled to occur in July. We expect to announce top line data late in the third or early in the fourth calendar quarter of 2008 and to submit our New Drug Application in December. Like all three approved rapid acting insulins, and at the request of the FDA, VIAject(TM)'s pivotal studies are against regular human insulin. We believe VIAject(TM)'s ultra rapid PK/PD profile will produce comparative safety and weight advantages against regular human insulin that have never before been demonstrated by any meal-time insulin. In addition, our market research suggests VIAject(TM)'s existing Phase I and Phase II comparative data against Humalog(R), coupled with successful Phase III data, will lead physicians to prescribe VIAject(TM) to both new patients and patients suffering from frequent hypoglycemic events."

Three Months Ended March 31, 2008

Biodel reported no revenue during the three months ended March 31, 2008 and March 31, 2007.

Biodel reported a net loss for the three months ended March 31, 2008 of $9.6 million, or $0.43 per share, as compared to a net loss applicable to common stockholders of $9.7 million, or $1.79 per share, for the comparable period in the prior year. Net loss for the quarter ended March 31, 2007 included a $4.5 million deemed dividend charge. Net loss for the quarter ended March 31, 2008 includes $1.7 million of stock-based compensation expenses. The stock-based compensation charge includes $0.5 million of stock-based compensation charges for options awarded annually to the board of directors.

Research and de
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
2. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
3. Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
4. Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007
5. Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on October 8, 2007
6. Brian J.G. Pereira, M.D. Joins Biodels Board of Directors
7. Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007
8. Biodel Inc. Announces Pricing of Public Offering
9. Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008
10. Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results
11. Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... led by George Washington University Professor Tianshu Li ... in small droplets is strongly size-dependent, an important ... The formation of ice at the nanoscale is ... also has important implications for climate research and ... from supercooled water is generally initiated by a ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, innovative ... Genzyme, a Sanofi company and leading biotech company, recently ... a multi-use facility in the United States. With Door ... this latest order underscores the satisfaction and success the ... device improving doorway access control. , “We recommend ...
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 NANONEX ... nanoimprint solutions , today announced the successful delivery ... manufacturing system, the NX-M200B, to a major Japanese ... is a fully-automated, production-ready, advanced nanoimprint lithography tool ... of wafer and substrate sizes and types. Based ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... GOTHENBURG, Sweden, July 22 Cellectricon, a leading,provider of ... its collaboration with University of Lodz, Poland. Under the,agreement ... for high throughput transfection enabling reagent-free delivery of any,genetic ... view the Multimedia News Release, please click: , ...
... , , MADISON, Wis., July ... today the appointment of Junying Yu , Ph.D., ... shown her to be one of the leading stem cell researchers ... accelerate the company,s efforts toward harnessing the power of induced pluripotent ...
... , , SALT LAKE ... spine care through the development of molecular diagnostics, and the ... a collaboration that allows Axial access to the University,s rich ... a genealogical and family history database composed of more than ...
Cached Biology Technology:University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer 2Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International 2Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International 3Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International 4Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders 2Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders 3
(Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
(Date:5/21/2013)... scientists have developed many devices that can reopen clogged ... effective, each of these treatments has drawbacks, including the ... MIT analyzes the potential usefulness of a new treatment ... stents, but may pose fewer risks. With this new ... only a brief period, during which it releases a ...
(Date:5/21/2013)... The epigenetic modifications, which alter the way genes ... apparently be detected in the blood of pregnant ... way to foretell depression in the weeks after ... symptoms become debilitating. , The findings of the ... online in the journal Molecular Psychiatry . ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... for tens of thousands of heart patients to have high-tech ... defibrillators, the expensive devices are designed to shock damaged hearts ... which kills 300,000 Americans each year. , But a new ... from their ICDs, a large number won't -- and a ...
... again? It happens, you know. , As we ... our brains--have to "speak" more loudly to get the ... of Delaware researcher Christopher Knight, an assistant professor in ... result of age-related changes in muscle and neurons, elderly ...
... the amount of three particular proteins on their surface increases, ... related receptor proteins, called GPR3, GPR6 and GPR12, on nerve ... researchers increased the amount of the three proteins, the cells ... those on nerve cells with normal levels of the proteins, ...
Cached Biology News:Are one-third of costly implanted heart devices unnecessary? New study suggests yes 2Are one-third of costly implanted heart devices unnecessary? New study suggests yes 3When your brain talks, your muscles don't always listen 2When your brain talks, your muscles don't always listen 3When your brain talks, your muscles don't always listen 43 proteins may play important role in nerve-cell repair 2
Proliferin (C-14)...
... power of your ValveBank system! Program ... a Macintosh computer using graphic 'click-and-drag' timebars. ... print out program listings, then download your ... simple step., EasyCode is used for programming ...
... Jouan MSC series of Class II ... conditions and certification to the world's ... ensures that the cabinets cannot be ... Natural lighting, low noise and arm ...
... The Holten MaxiSafe 2010 Class ... most ergonomical working condition of comfort ... safety, efficiency and performance.,Refined operator, environment ... of both exhausted and recirculated air.,Bottom ...
Biology Products: